PEG

Pomalidomide-PEG6-NH2 hydrochloride is a compound resulting from the synthesis of an E3 ligase ligand-linker conjugate, combining the cereblon ligand derived from Pomalidomide with a 6-unit PEG linker, specifically designed for application in PROTAC technology.

Thalidomide-PEG4-NH2 hydrochloride is an E3 ligase ligand-linker conjugate compound, comprising the cereblon ligand from Thalidomide and a linker specifically used in PROTAC technology.

A 410099.1 amide-PEG2-amine-Boc is a functionalized IAP ligand for PROTACs, combining an IAP ligand with an amide-PEG3 linker terminating in an amine, facilitating the formation of conjugates with target protein ligands.

A 410099.1 amide-PEG3-amine-Boc is an IAP ligand-based functionalized molecule commonly used in PROTACs, consisting of an IAP ligand and an amide-PEG3 linker with a terminal amine. The compound effectively conjugates with target protein ligands.

Pomalidomide-PEG3-C2-NH2 hydrochloride, also known as Cereblon Ligand-Linker Conjugate 5, is a chemically synthesized E3 ligase ligand-linker conjugate. This compound incorporates a cereblon ligand based on Pomalidomide and a linker commonly employed in PROTAC technology.

mPEG-DSPE sodium (DSPE-mPEG2000 sodium) is a PROTAC linker belonging to PEG and is involved in the synthesis of PROTAC molecules.

14:0 PEG2000 PE (DMPE-PEG2000) is a polyethylene glycol (PEG)-phospholipid conjugate that prevents vesicle aggregation during vesicle formulation and is useful in the preparation of nanostructured lipid carriers.

Gly-Gly-Gly-PEG4-azide functions as a cleavable linker for antibody-drug conjugates (ADCs), facilitating their synthesis [1].

Pomalidomide 4'-PEG5-amine, a cereblon ligand designed for PROTAC research and development, features an integrated E3 ligase ligand and a PEG5 linker ending in an amine for easy conjugation to target protein ligands. It is among a series of functionalized tool molecules specifically crafted for PROTAC R&D.